SUNWELS Co.,Ltd.

9229 株式会社サンウェルズ

Medical Care Facilities · Prime

PRICE: ¥148 · MKT CAP: ¥5.2B · P/E: — · P/B: 0.69x · DIV YIELD: 0.0%

PRICE — 5Y

Characteristics & Business Summary

Sunwels Co.,Ltd. operates nursing care business centered on PD house. It operates homes for the elderly that specializes in Parkinson disease, as well as a Kaatsu training gym; provides day care, in-home care support, care plan, and home remodeling services...

Income Statement Highlights (¥ Million, except EPS/DPS in ¥)

Fiscal Period	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Forecast
Net Sales	8,420	13,717	21,360	26,496	28,136	28,872
Operating Profit	490	1,434	3,490	1,114	-1,223	420
Ordinary Profit	349	1,141	2,938	388	-2,168	—
Net Profit	256	784	2,032	-925	-1,656	-1,060
EPS	¥22	¥67	¥58	¥-26	¥-47	—
DPS	¥11	¥26	¥14	¥0	¥0	—

Balance Sheet & Valuation Highlights

Total Assets ¥46B

Net Assets (Equity) ¥7B

Equity Ratio 15.2%

ROE (Return on Equity) -23.9%

Cash & Equivalents ¥4B

Interest-Bearing Debt ¥6B

Capital Expenditure (CapEx) ¥1B

Depreciation & Amort. ¥2B

Major Shareholders

1. 株式会社杏 41.6%
2. 苗代亮達 12.0%
3. Citibank, N.A. 5.0%
4. DBS BANK LTD.700104（常任代理人株式会社みずほ銀行決済営業部） 5.0%
5. BNY Mellon (Nominee) 3.2%
6. Morgan Stanley 2.5%
7. The Master Trust Bank of Japan, Ltd. (Trust Account) 2.2%
8. BNP PARIBAS LONDON BRANCH FOR PRIME BROKERAGE CLEARANCE ACC FOR THIRD PARTY（常任代理人香港上海銀行東京支店） 1.3%
9. BNP PARIBAS SINGAPORE/2S/JASDEC/MAYBANK CLTASET 30E-0B（常任代理人香港上海銀行東京支店） 1.1%
10. Citibank, N.A. 1.0%

Activist Activity

UBS AG 4.98%

2026-02-20 · change

UBS AG 5.05%

2025-12-22 · change

Ryotatsu Nawashiro 49.42%

2025-10-06 · change

UBS AG 5.13%

2025-06-20 · change

UBS AG 6.27%

2025-04-22 · change

Historical Per-Share Data & Valuation Ratios

Per Share Metric	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Forecast
Revenues per share	¥717	¥1,168	¥606	¥752	¥799	—
FCF/Share	¥-6	¥-63	¥-83	¥-66	¥-43	—
EPS	¥22	¥67	¥58	¥-26	¥-47	—
DPS	¥11	¥26	¥14	¥0	¥0	—
Capital Spending per share	¥39	¥160	¥156	¥119	¥33	—
Book Value per share	¥74	¥457	¥202	¥244	¥197	—
Common Shares Outstanding	12M	12M	35M	35M	—	—

Financial Aggregates & Margins

Financial Aggregate	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Forecast
Revenues (Net Sales)	¥8B	¥14B	¥21B	¥26B	¥28B	¥29B
Operating Margin (%)	5.8%	10.5%	16.3%	4.2%	-4.3%	1.5%
Net Profit (owners)	¥0B	¥1B	¥2B	¥-1B	¥-2B	¥-1B
Net Profit Margin (%)	3.0%	5.7%	9.5%	-3.5%	-5.9%	-3.7%
Working Capital	¥-6B	¥-8B	¥-17B	¥-20B	¥-29B	—
Total Debt (Interest-bearing)	¥3B	¥2B	¥6B	¥7B	¥6B	—
Net Worth (Common Equity)	¥1B	¥5B	¥7B	¥9B	¥7B	—
Return on Total Assets (ROA)	2.8%	4.1%	6.4%	-2.4%	-3.6%	—
Return on Common Equity (ROE)	29.6%	14.6%	28.5%	-10.8%	-23.9%	—

Business Summary & Analysis

Capital Strategy Targets

No active capital policy disclosure records found.